Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00842946 · ClinicalTrials.gov registry record · NA
Exposure With Acceptance-Based Versus Habituation-Based Rationale for Public Speaking Anxiety
A NA study, sponsored by Drexel University.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT00842946: Completed NA study, sponsored by Drexel University.
NCT00842946 is a NA study that has completed, run by Drexel University. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00842946, a NA study, has completed, sponsored by Drexel University.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to compare two exposure-based behavioral group treatments for public speaking anxiety. Specifically, exposure within the context of psychological acceptance will be compared to exposure within a standard habituation context. It is hypothesized that participants receiving exposure within the context of psychological acceptance will experience a greater decrease in anxiety and greater improvement in quality of life compared to the habituation-based group.
Primary Outcome
The SCID (First, Spitzer, Gibbon, \& Williams, 1996) is an extensively utilized structured diagnostic interview based on DSM-IV criteria. Estimates of interrater reliability range from moderate to high for most Axis I disorders (e.g., Williams et al., 1992; Zanarini \& Frankenburg, 2001).
Interventions
- BEHAVIORAL Exposure w/ Acceptance-Based Rationale
- BEHAVIORAL Exposure w/ Habituation-Based Rationale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2009-02 |
| Est. Completion | 2009-11 |
| Phase | NA |
What the finished NCT00842946 record still lists
NCT00842946 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Exposure w/ Acceptance-Based Rationale is the first listed.
NCT00842946 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00842946 about?
NCT00842946 is a clinical study titled "Exposure With Acceptance-Based Versus Habituation-Based Rationale for Public Speaking Anxiety". The purpose of this study is to compare two exposure-based behavioral group treatments for public speaking anxiety. Specifically, exposure within the context of psychological acceptance will be compared to exposure within a standard habituation context. It is hypothesized that participants receiving...
What is the current status of trial NCT00842946?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2009-02. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00842946?
The interventions under investigation include: Exposure w/ Acceptance-Based Rationale (BEHAVIORAL), Exposure w/ Habituation-Based Rationale (BEHAVIORAL).
Who is sponsoring clinical trial NCT00842946?
This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00842946's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia